What is Blood Flow Measurement Market?
Blood flow measurement is a crucial health factor that is to be measured before a wide number of medical tests and surgeries. Also, in the geriatric population, it is a part of regular checkups. The Measurement devices need to be efficient and at par with the medical service being provided. The increasing market value is because of increased investments in Healthcare and the prevalence of cardiovascular diseases. Additionally, the prevalence of hypertension and rising clinical applications are predicted to fuel the blood flow measurement market.
Highlights from Blood Flow Measurement Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Transonic Systems, Inc. (United States), Cook Medical, Inc. (United States), Medistim ASA (Norway), Compumedics Ltd. (Australia), ADInstruments (Australia), Deltex Medical Group plc (United Kingdom), BIOPAC Systems, Inc. (United States), Atys Medical (France), Moor Instruments Ltd. (United Kingdom) and SONOTEC Ultraschallsensorik Halle GmbH (Germany). |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European and United States Players will contribute to the maximum growth of Global Blood Flow Measurement market throughout the forecasted period.
Transonic Systems, Inc. (United States), Cook Medical, Inc. (United States), Medistim ASA (Norway), Compumedics Ltd. (Australia), ADInstruments (Australia), Deltex Medical Group plc (United Kingdom), BIOPAC Systems, Inc. (United States), Atys Medical (France), Moor Instruments Ltd. (United Kingdom) and SONOTEC Ultraschallsensorik Halle GmbH (Germany). are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Perimed AB (Sweden) and Perflow Medical Ltd. (Israel). Blood Flow Measurement Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Non-invasive {Cardiovascular Disease, Diabetes, Tumor Monitoring, Gastroenterology, and Others (Dermatology and Intracranial Pressure Monitoring in Brain Injury)} and Invasive {CABG, Microvascular Surgery, and Others (Reconstructive Surgery and Organ Transplantation) |
Type | Ultrasound (Ultrasound Doppler, and Transit-time Flow Meters (TTFM)) and Laser Doppler |
End User | Hospitals,Diagnostic Centers,Pharmaceutical Companies,Biotechnology Companies,Contract Research Organizations,Academic Research Institutes |
On the basis of geography, the market of Blood Flow Measurement has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Healthcare Spending by the Various Government
Market Growth Drivers:
Rising Prevalence of Cardiovascular Disease and Diabetes Coupled and Increasing Geriatric Population across the Globe
Challenges:
Lack of Skilled Working Professionals
Restraints:
Development of Alternative Methods to Treat Cardiovascular Diseases is Restraining the Market Growth for Transit-Time Flow Meters
Opportunities:
Highly Unpenetrated Market for Transit-Time Blood Flow Meters, Emerging Markets Across India and China and Increased Funding for Technological Advancement
Key Target Audience
Blood Flow Measurement Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Market Leaders & Development Strategies
In March 2021, Cardiovascular Systems, Inc. announced today that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC.
In March 2021, Perflow Medical, an Israel-based developer of neurovascular devices, announced the launch of the Cascade17 nonocclusive remodeling net in Europe. The neurovascular device is designed for the support of distal and tortuous vessel anatomy during coil embolization of intracranial aneurysms of smaller vessels.